As per our report, the size of the global 3D cell culture market is estimated to worth USD 1.81 billion by 2025, growing at a CAGR of 14.8% during the forecast period.
3D Cell culture is a feigned generated environment in which biological cells are stored and allowed to grow within the surrounding environment. In general, 3D cell cultures are used for the research of cell tissues for decades. The 3D process of cell culture has begun in the early 20th century to enlarge the expansion of in-vitro tissue cultures. These procedures are being used for in-vitro diseases used to identify cellular responses to the pharmaceutical composition. These 3D cell cultures have a long period of endurance.
This 3D cell culture is used to study the diseases, mainly to figure out the disease stage. Further, the applications expanded to areas such as regenerative medicine, tissue engineering, biomedical and clinical studies. The presence of 3D cell culture plays a vital role in in-vitro cell responses and stem cells, cancer cells, etc.
MARKET DRIVERS
The advantages associated with the 3D cell culture to avoid the flaws of 2D monolayer cultures are expected to drive market growth.
Growing adoption of 3D over 2D and the availability of enormous market potential are expected to lavish the 3D cell culture market in the coming years. Increasing technological advancements related to 3D cell culture to do better R & D of cell tissues is also providing a significant boost to the market growth. In the last few years, the focus to develop alternatives for animal testing is growing significantly, which is expected to provide growth opportunities to the global 3D cell culture market. 3D cell culture in examining the drugs and manufacturing vaccines and biopharmaceuticals further accelerate the market growth.
Additionally, factors such as growing focus on developing alternatives to animal testing, rising emphasis on personalized medicine, an increase in the incidence of chronic diseases, and funds available for research contributions to the growth of the global 3D cell culture market. The rise in demand for organ transplantation and tissue engineering to treat chronic diseases are also expected to drive the market.
MARKET RESTRAINTS
Lack of proper infrastructure and high costs associated with the R & D of 3D cell culture limit market growth. The shortage of investments by the government bodies and other organizations is also expected to hamper the market growth to a limited extent. The lack of skilled clinicians and lab technicians in the 3D cell culture industry is also showing a minor negative impact on the market. Stringent rules and regulations by the government are even slowly declining the growth rate of the market.
Impact of Covid-19 On 3d Cell Culture Market:
The 3D cell culture market has been positively affected by the COVID-19 pandemic. To develop novel therapies, there is a surge in research practices against COVID-19, which is serving tremendous opportunities for market key players. Regenerative medicine and stem cell therapies are associated with research showing promising results for treating COVID-19 pandemic disease. The market shares will fall into the normal state by 2021.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Product, Application, End-User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the global 3d cell culture market has been segmented and sub-segmented based on the product, application, end-user, and region.
3D Cell Culture Market - By Product:
Based on the Product, the scaffolding 3D cell culture segment was the dominating segment in 2019 and expected to showcase the highest CAGR in the forecast period. The steady growth of this segment is attributed to the ability of scaffolding products to mimic in vivo conditions, which favors their adoption by end-users.
3D Cell Culture Market - By Application:
Based on the Application, the stem cell and cancer segment represented the largest market share in 2019. This segment of applications' growth is attributed to the growing incidence of cancer and important funding initiatives for cancer research by governmental and private organizations.
3D Cell Culture Market - By End User:
Based on the End User, the Pharmaceutical & Biotechnology Companies segment is accounting largest share by registering the highest compound annual growth rate in 2019. Increment of R&D spending in companies, the presence of numerous pharmaceutical & biotechnology companies, and growth in preference of alternative tests model over animal techniques are significant factors to drive the market by the End-User segment.
3D Cell Culture Market - By Region
Geographically, the global market is dominated by North America in 2019, followed by Europe, Asia-Pacific, and the rest of the world. Availability of funds by the government, private for development, advanced technology framework to support rapid detection of chronic diseases, and high spending on healthcare is the North America region's attributing factors. Rise in incidences of diseases copulation with infrastructure development, improving therapies, rise in increases in the rate of diseases are also drivers in drug development and discovery. United States 3d cell culture market is leading the North American market, followed by Canada. Factors such as the increase in cancer incidence, the presence of well-established pharmaceutical and biotechnological industries, and the availability of technologically advanced products are majorly driving the market growth in this region.
The European 3d cell culture market is the second global leader in 3D cell culture and is dominated by counties like the United Kingdom, Spain, Italy, France, and Germany. Recently growing demand for micro fluids commercialization and research is the foremost opportunity for the market. The continuous interest shown by the European countries in research on oncology diseases gives fuel to the market size. The rise in the number of patients who have cancer is leveling up the demand of the market. Also, increasing research on stem cell for regenerative medicines create a space for new market opportunities.
Asia Pacific 3d cell culture market region is expected to grow at the highest share during the forecast period. Hoping that the Asia-Pacific region will grow fast by recording rate in the 3D cell culture market. The translation of large people affected by diseases is by low prevalence rates driving factors in the 3D cell culture market. Moreover, the adoption of cell-based healthcare approaches is also a factor for market growth in the 3D cell culture market. China and India are the significant countries offering significant support for the 3D cell culture market in the Asia Pacific region. Besides, Japan and South Korea are also contributing well to expand the market size in this Region. The Asia Pacific 3D cell culture market is majorly driven due to the strong presence of various significant players in the pharmaceutical and biotech industries in China and India. The rising demand for cancer-related drugs is market growth in this region. Also, increasing the Application of 3D cell culture for study and drug developments is enhancing the need of the market.
TOP COMPANIES IN THE MARKET
Some of the key market participants leading the Global 3D Cell Culture Market profiled in this report are MIMETAS, Hamilton Company, CN Bio, Advanced BioMatrix, Merck KGaA, REPROCELL Incorporated, Thermo Fisher Scientific, 3D Biotek, Lonza AG, Corning Incorporated, TissUse, PromoCell, InSphero, and Synthecon.
RECENT MARKET DEVELOPMENTS
On January 23, 2020, the Hystem line of products was acquired by Advanced BioMatrix from Lineage Cell Therapeutics. Hystem kits are built on new hyaluronic acid technology. This acquisition involves the shifting of applied sciences, intellectual property for research, and development purposes.
On April 05, 2019, MIMETAS announced the launch of its new laboratory associated with the 3D microfluidic cell culture device OrganoPlate. The start of the new laboratory provides MIMETAS with new dimensions for growth. The OrganoPlate bears the 3D cell culture under steady intromission.
On March 21, 2017, Greiner Bio-One has united with Nano3D Biosciences to bring up a new perimeter in biotechnology by acquiring the products from 3D cell culture. This collaboration works combined to oblige physical utilization of growing cell cultures that offer benefits to increase the exploratory outcomes.
Related Reports
Feb 2020
Feb 2020
Feb 2020
Feb 2020
